Cued memory decline in biomarker-defined preclinical Alzheimer disease

OBJECTIVE: To determine whether a decline in cued recall is observable in the preclinical stage of Alzheimer disease (AD) in clinically normal older adults with elevated β-amyloid (Aβ) burden on PET imaging. METHODS: Clinically normal older adults underwent baseline neuroimaging (PET to assess Aβ(+/...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neurology
Prif Awduron: Papp, Kathryn V., Rentz, Dorene M., Mormino, Elizabeth C., Schultz, Aaron P., Amariglio, Rebecca E., Quiroz, Yakeel, Johnson, Keith A., Sperling, Reisa A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Lippincott Williams & Wilkins 2017
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5386436/
https://ncbi.nlm.nih.gov/pubmed/28283594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003812
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg